Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19190908rdf:typepubmed:Citationlld:pubmed
pubmed-article:19190908lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19190908lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:19190908lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:19190908lifeskim:mentionsumls-concept:C0069717lld:lifeskim
pubmed-article:19190908lifeskim:mentionsumls-concept:C0879262lld:lifeskim
pubmed-article:19190908lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:19190908lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:19190908pubmed:issue5lld:pubmed
pubmed-article:19190908pubmed:dateCreated2009-8-18lld:pubmed
pubmed-article:19190908pubmed:abstractTextTo determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy on metastatic gastric cancer.lld:pubmed
pubmed-article:19190908pubmed:languageenglld:pubmed
pubmed-article:19190908pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:citationSubsetIMlld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19190908pubmed:statusMEDLINElld:pubmed
pubmed-article:19190908pubmed:monthOctlld:pubmed
pubmed-article:19190908pubmed:issn1432-0843lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:KimMin-JeongM...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:KimJung HanJHlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:KimHyo JungHJlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:JangKyung...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:SongHun HoHHlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:JungJoo...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:ZangDae...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:KimHyeong...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:KwonJung...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:KimHo YoungHYlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:YooKyo-SangKSlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:ParkSarahSlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:YangDae...lld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:HwangSe WonSWlld:pubmed
pubmed-article:19190908pubmed:authorpubmed-author:HanTaehoTlld:pubmed
pubmed-article:19190908pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19190908pubmed:volume64lld:pubmed
pubmed-article:19190908pubmed:ownerNLMlld:pubmed
pubmed-article:19190908pubmed:authorsCompleteYlld:pubmed
pubmed-article:19190908pubmed:pagination877-83lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:meshHeadingpubmed-meshheading:19190908...lld:pubmed
pubmed-article:19190908pubmed:year2009lld:pubmed
pubmed-article:19190908pubmed:articleTitleDose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.lld:pubmed
pubmed-article:19190908pubmed:affiliationDepartment of Internal Medicine, Hallym University Medical Center and Hallym University College of Medicine, Anyang, South Korea. fhdzang@hallym.or.krlld:pubmed
pubmed-article:19190908pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19190908pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19190908lld:pubmed